Day: July 1, 2020

VICTOR, N.Y., July 01, 2020 (GLOBE NEWSWIRE) — Constellation Brands, Inc. (NYSE: STZ and STZ.B), a leading beverage alcohol company, announced today its purchase of Empathy Wines, a high-performing, digitally-native wine brand and direct-to-consumer (DTC) platform co-founded by entrepreneur and media personality Gary Vaynerchuk with business partners Jon Troutman and Nate Scherotter. Empathy Wines focuses on producing high quality, sustainably made wines, sold direct-to-consumer through its eCommerce platform, powered by consumer insights and content-driven digital marketing.This move aligns with Constellation’s wine and spirits vision to be a bold and innovative, high-end portfolio of distinctive brands and products that deliver exceptional consumer experiences. As part of the agreement, Constellation will work with the Empathy...

CAMBRIDGE, Mass., July 01, 2020 (GLOBE NEWSWIRE) — Evelo Biosciences, Inc. (Nasdaq:EVLO), a clinical stage biotechnology company developing a new modality of orally delivered, systemically acting biologics, today announced that clinical data from the Phase 1/2 open-label study of EDP1503, in combination with pembrolizumab, in patients with advanced metastatic microsatellite stable colorectal carcinoma (MSS CRC), triple-negative breast cancer (TNBC), and checkpoint inhibitor relapsed tumors, will be presented at the ESMO World Congress on Gastrointestinal Cancer Virtual Meeting being held July 1 – 4, 2020.In addition to data in MSS CRC patients, the poster reported preliminary data on 11 TNBC patients (8 on high dose and 3 on low dose EDP1503). An overall response rate (ORR) of 25% (2/8) and a disease control rate of 37.5%...

SALT LAKE CITY, July 01, 2020 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics and precision medicine, today announced the launch of a new patient home collection kit for the GeneSight® Psychotropic test. The kit allows the DNA sample collection typically administered in a clinician’s office to be completed at home. The new direct-to-patient collection kit must still be ordered by a licensed healthcare provider.“We’ve seen an unprecedented rise in mental health issues including depression and anxiety due to the pandemic. A recent survey from John Hopkins University Bloomberg School of Public Health showing a three-fold increase in the number of adults experiencing psychological distress,” said Mark S. Verratti, president of Myriad Neuroscience and Myriad Autoimmune. “At the same time, more...

GOLETA, Calif., July 01, 2020 (GLOBE NEWSWIRE) — Resonant Inc. (NASDAQ: RESN), a leader in transforming the way radio frequency, or RF, front-ends are being designed and delivered for mobile handset and wireless devices, announced it will host a conference call with Loop Capital on Wednesday, July 8, 2020.Loop Capital Virtual Fireside Conversation with Resonant ManagementWednesday, July 8, 2020 at 10:00 am PT / 1:00 pm ETFeaturing Chairman & CEO George B. Holmes, COO Dylan Kelly, and Advisor Mike EddyHosted by Cody Acre, Managing DirectorPlease call your Loop Capital representative or LHA Investor Relations at 415-433-3777 for a dial-in. Please note a webcast of the presentation will be posted to the Resonant Investor Relations Events section shortly after the call.About Resonant Inc.Resonant (NASDAQ: RESN) is transforming...

NEW YORK, July 01, 2020 (GLOBE NEWSWIRE) — Nasdaq (Nasdaq: NDAQ) announced today that in the first half of 2020 it welcomed 69 initial public offerings (IPOs), raising a total of $17.4 billion, extending its leadership to 26 consecutive quarters. A total of 55 operating companies listed during the first six months of 2020, representing an 85 percent win rate in the U.S. market. In addition to the IPOs, five companies switched from the NYSE to join Nasdaq.Through the first two quarters of 2020, Nasdaq-listed companies raised 77 percent of all IPO proceeds of operating companies, including four of the five largest IPOs by capital raised: Royalty Pharma (raised $2.18B), Warner Music Group (raised $1.93B), PPD (raised $1.62B), and Reynolds Consumer Products (raised $1.23B).In addition to the remarkable quarters in IPOs, Nasdaq took...

SCOTTSDALE, Ariz., July 01, 2020 (GLOBE NEWSWIRE) — The Joint Corp. (NASDAQ: JYNT), a national operator, manager and franchisor of chiropractic clinics, announced it has opened two corporately-managed clinics in the Los Angeles area on June 1st and July 1st. This increases the regional cluster of corporate and franchised clinics to 30 and The Joint total corporate clinic portfolio to 63.Peter D. Holt, President and Chief Executive Officer of The Joint Corp., said, “Due to strong performance in the Los Angeles region, including our greenfield clinic opened in February 2020, this market continues to be an important focus for our corporate clinic expansion. With the onset of COVID-19, we paused our clinic development to carefully monitor the situation. Since then, as we have experienced increasingly solid patient visits during this...

NEW YORK, July 01, 2020 (GLOBE NEWSWIRE) — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases including Alzheimer’s disease, Parkinson’s disease, Rett syndrome and other central nervous system (CNS) diseases, today announced that the first patient was dosed in the EXCELLENCE Phase 2/3 ANAVEX®2-73-RS-003 clinical trial for the treatment of Rett syndrome with ANAVEX®2-73 (blarcamesine).The Phase 2/3 study will use a convenient once-daily oral liquid ANAVEX®2-73 (blarcamesine) formulation to treat Rett syndrome. Safety and efficacy will be investigated in at least 69 patients over a 12-week treatment period including ANAVEX®2-73-specific precision medicine biomarkers....

WYOMISSING, Pa., July 01, 2020 (GLOBE NEWSWIRE) — Gaming and Leisure Properties, Inc. (NASDAQ: GLPI) today announced that the Company will release its 2020 second quarter financial results after the market close on Thursday, July 30, 2020.  The Company will host a conference call at 9:00 a.m. ET on Friday, July 31, 2020.During the conference call, Peter M. Carlino, Chairman and Chief Executive Officer, and Steven T. Snyder, Senior Vice President, Chief Financial Officer, will review the quarter’s results and performance, discuss recent events and conduct a question-and-answer period.Webcast:The conference call will be available in the Investor Relations section of the Company’s website at www.glpropinc.com. To listen to a live broadcast, go to the site at least 15 minutes prior to the scheduled start time in order to register, download...

BALA CYNWYD, Penn., July 01, 2020 (GLOBE NEWSWIRE) — Leading private markets asset management firm Hamilton Lane (NASDAQ: HLNE) today announced the final closing of the Hamilton Lane Impact Fund (the “Fund”) with total capital commitments of more than $95 million. The Fund has a dual focus designed to generate both attractive investment returns and positive social and environmental impact.The Fund will invest in businesses globally through direct investments and primary or secondary investments, with a focus on the core impact sectors of health and wellness, energy and environment, community development, and financial empowerment. Leveraging Hamilton Lane’s broad network and robust platform of deal flow and GP relationships, the Fund will seek investments across diversified private markets strategies—including buyout, growth, venture...

ALACHUA, Fla., July 01, 2020 (GLOBE NEWSWIRE) — Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced a financing agreement with Oberland Capital and provided preliminary, estimated revenue for the second quarter ended June 30, 2020.SummaryFinancing agreement provides up to $75.0 million in three tranches with interest only payments over seven years$35.0 million drawn by the Company upon closing the agreement on June 30, 2020Preliminary second quarter revenue is estimated to be at least $21 million, down 21% versus prior year“We are pleased to announce this new debt facility with Oberland Capital,” noted Peter J. Mariani, chief financial officer of Axogen. “The addition of this facility further strengthens our balance sheet and supports...